COMMUNIQUÉS West-GlobeNewswire

Immunicum AB (publ) Announces Upcoming Presentations at Conferences in August and September
22/08/2017
Press Release 22 August 2017 Immunicum AB (publ) Announces Upcoming Presentations at Conferences in August and September Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel, [...]
Herantis Pharma's Manager's Transactions
22/08/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Herantis Pharma's Manager's Transactions
22/08/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Herantis Pharma's Manager's Transactions
22/08/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Herantis Pharma's Manager's Transactions
22/08/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Herantis Pharma's Manager's Transactions
22/08/2017
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Bavarian Nordic Announces Closing of Transaction with Janssen Pharmaceuticals, Inc. and Issue of Shares to Johnson & Johnson Innovation - JJDC, Inc.
21/08/2017
COPENHAGEN, Denmark, August 21, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced the closing of the transaction with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of [...]
Sanofi : Disclosure of trading in own shares
21/08/2017
Disclosure of trading in own shares This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]
Sanofi : Déclaration des transactions sur actions propres
21/08/2017
Déclaration des transactions sur actions propres This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are [...]
Medtronic Receives CE Mark for Attain Stability(TM) Quad MRI SureScan(TM) Active-Fixation Heart Lead
21/08/2017
Clinical Trial Also Underway in U.S., Canada and Other Geographies DUBLIN - August 21, 2017 - Medtronic plc (NYSE: MDT) announced it has received CE ( Conformité Européene ) Mark for the Attain Stability(TM) Quad MRI [...]
CORRECTION - Ossur Hf : Transactions in relation to share buyback program
21/08/2017
This is a correction of the announcement from 16:00 21.08.2017 CEST, NO: 61/2017. Reason for the correction: Header incorrect, other information in the announcement is correct. Previous Header: Share buyback program [...]
PCI Biotech: Invitation to first half year 2017 presentation
21/08/2017
Oslo, 21 August 2017 - PCI Biotech invites to a presentation of the company's second quarter and first half year 2017 report on Tuesday 29 August 2017 at Oslo Cancer Cluster Innovation Park. Time: Tuesday August 29, [...]
Ossur Hf : Share buyback program completed
21/08/2017
Announcement from Össur hf. No. 61/2017 Reykjavík, 21 August 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program was to [...]
Novo Nordisk A/S - Share repurchase programme
21/08/2017
Bagsværd, Denmark, 21 August 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Shire plc Director and Senior Management Changes
21/08/2017
Shire plc Director and Senior Management Changes August 21, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) ("Shire" or the "Company"), announces changes to its Executive Committee, as it progresses its strategy to sharpen [...]
PDMR Dealing
21/08/2017
LONDON, Aug. 21, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Navamedic ASA: Enters into partnership agreement for distribution of ELMIRON® in the Nordics
21/08/2017
Oslo, August 21, 2017 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a long term agreement with bene-Arznemittel GmbH (bene) for the Nordic [...]
Saniona AB: Saniona's partner, Medix, initiates Phase 3 study for tesofensine in obesity
21/08/2017
PRESS RELEASE 21 August 2017 Saniona, a leading biotech company in the field of ion channels, today announces that Medix has recruited the first patients in the Phase 3 clinical study for tesofensine in Mexico. This [...]
Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156, a novel compound against multidrug-resistant malaria
21/08/2017
Compound has potential to be a game-changer in malaria elimination, rapidly clearing malaria infection, including resistant strains, and blocking parasite transmission KAF156 is first compound from the [...]

Pages